COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03035058
Brief Title: Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease

First Submitted : January 25, 2017
First Submitted that Met QC Criteria : January 25, 2017
First Posted : January 27, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : March 7, 2017
Last Update Posted : March 8, 2017